SCHEPIS, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.651
AS - Asia 6.909
EU - Europa 5.683
SA - Sud America 1.168
AF - Africa 190
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 15
Totale 26.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.421
SG - Singapore 2.129
CN - Cina 2.000
GB - Regno Unito 1.640
IT - Italia 1.112
BR - Brasile 887
VN - Vietnam 784
HK - Hong Kong 752
DE - Germania 721
SE - Svezia 484
FI - Finlandia 447
RU - Federazione Russa 309
KR - Corea 251
FR - Francia 233
UA - Ucraina 195
TR - Turchia 169
ID - Indonesia 143
IN - India 136
BD - Bangladesh 113
AR - Argentina 101
CA - Canada 99
BG - Bulgaria 93
MX - Messico 88
NL - Olanda 73
ES - Italia 64
JP - Giappone 64
PL - Polonia 53
ZA - Sudafrica 49
AE - Emirati Arabi Uniti 48
IQ - Iraq 46
CO - Colombia 41
BE - Belgio 40
PK - Pakistan 39
EC - Ecuador 36
LT - Lituania 34
MA - Marocco 34
AT - Austria 33
AU - Australia 33
EG - Egitto 27
VE - Venezuela 25
CL - Cile 24
PH - Filippine 22
RO - Romania 22
UZ - Uzbekistan 22
MY - Malesia 19
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
KE - Kenya 18
PY - Paraguay 18
DZ - Algeria 16
PE - Perù 16
IE - Irlanda 15
NP - Nepal 15
TH - Thailandia 14
TN - Tunisia 14
AZ - Azerbaigian 12
IL - Israele 12
CH - Svizzera 11
KZ - Kazakistan 11
AL - Albania 10
BH - Bahrain 10
SK - Slovacchia (Repubblica Slovacca) 10
UY - Uruguay 10
BO - Bolivia 9
BY - Bielorussia 9
JO - Giordania 8
CR - Costa Rica 7
DO - Repubblica Dominicana 7
GE - Georgia 7
LB - Libano 7
LV - Lettonia 7
PT - Portogallo 7
SC - Seychelles 7
EU - Europa 6
GR - Grecia 6
JM - Giamaica 6
KG - Kirghizistan 6
PA - Panama 6
RS - Serbia 6
XK - ???statistics.table.value.countryCode.XK??? 6
CY - Cipro 5
HR - Croazia 5
HU - Ungheria 5
IR - Iran 5
NZ - Nuova Zelanda 5
QA - Qatar 5
SI - Slovenia 5
AM - Armenia 4
BZ - Belize 4
EE - Estonia 4
HN - Honduras 4
KH - Cambogia 4
NI - Nicaragua 4
SN - Senegal 4
SY - Repubblica araba siriana 4
DK - Danimarca 3
ET - Etiopia 3
FJ - Figi 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 26.603
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.376
Ashburn 1.295
Singapore 1.269
Fairfield 1.227
Southend 972
Hong Kong 728
Woodbridge 726
Hefei 722
Chandler 600
Houston 574
Seattle 491
London 431
Cambridge 417
Wilmington 415
Helsinki 377
San Jose 357
Ann Arbor 327
Modena 324
Nyköping 322
Jacksonville 310
Beijing 271
Ho Chi Minh City 256
Dearborn 255
The Dalles 245
Seoul 236
Dallas 230
Berlin 217
New York 207
Los Angeles 202
Hanoi 190
Chicago 184
Council Bluffs 148
San Diego 122
Lauterbourg 104
Princeton 96
Jakarta 94
Sofia 89
Moscow 81
Shanghai 78
São Paulo 77
Izmir 75
Frankfurt am Main 74
Bologna 67
Salt Lake City 65
Munich 64
Buffalo 56
Eugene 56
Milan 55
Orem 55
Tokyo 53
Redwood City 50
Grafing 39
Kent 39
Yalova 39
Da Nang 38
Rome 37
Warsaw 36
Nuremberg 35
Brooklyn 34
Des Moines 34
Elk Grove Village 34
Nanjing 34
Rio de Janeiro 34
Guangzhou 33
Tampa 33
Phoenix 32
Brussels 31
Redondo Beach 30
Haiphong 27
Jersey City 27
Boardman 26
Bremen 26
Columbus 26
Atlanta 25
Mexico City 25
Montreal 25
Chennai 24
Turku 24
Johannesburg 23
Falls Church 22
Brasília 21
Mumbai 21
Stockholm 21
Vancouver 21
Boston 20
Melbourne 20
Portsmouth 20
Tashkent 20
Toronto 20
Manchester 19
Amsterdam 18
Denver 18
Paris 17
Wuhan 17
Baghdad 16
Biên Hòa 16
Dhaka 16
Dubai 16
Nairobi 16
Changsha 15
Totale 18.572
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 698
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 473
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 457
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 439
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 427
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 423
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 403
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 386
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 368
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 358
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 347
A new device for ultrasound-guided peripheral venous access 345
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis 323
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. 305
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 303
30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice 299
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 298
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 295
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 295
Consensus conference on TIPS management: Techniques, indications, contraindications 293
JLB: a flexible and effective device in critical patients. Review of clinical cases 293
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 287
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 283
Obese zebrafish: A small fish for a major human health condition 282
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 280
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 279
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 266
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 266
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 263
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 262
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells. 261
Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. 260
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 260
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials 258
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 254
A RANDOMIZED TRIAL OF THE SAFETY AND HEPATIC HEMODYNAMIC EFFECTS OF INTRAVENOUS CONIVAPTAN IN EUVOLEMIC OR HYPERVOLEMIC CIRRHOTIC PATIENTS 247
Chemoprevention of hepatocellular carcinoma 246
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 245
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 244
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. 241
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS 234
Protection of human endothelial cells from oxidative stress: Role of Ras-ERK1/2 signaling 233
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 233
Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. 229
Baveno VII – Renewing consensus in portal hypertension 227
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? 225
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis” 224
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives 224
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. 222
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 222
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen? 218
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 215
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 215
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. 211
Natural history of chronic HBV in northern Italy: Morbidity and morality after 30 years 208
Paradoxical embolization in TIPS: take a closer look to the heart 207
The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45β2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway 207
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 205
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis 203
When and how to treat acute hepatitis C? 201
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 199
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 198
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 198
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis 197
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 196
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease 196
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 195
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure 194
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 193
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions 190
Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis 190
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 189
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 189
Transjugular intrahepatic portosystemic shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: a real-life, case-control study 188
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) 187
Pathophysiology of portal hypertension and variceal bleeding 179
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 178
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 177
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis 175
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 171
Akt1/Akt2 inhibition and development of hepatocellular carcinoma 170
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 164
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 163
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 161
Transient elastography and ultrasonography: Optimal evaluation of liver fibrosis and cirrhosis in patients with chronic hepatitis B concurrent with nonalcoholic fatty liver disease 161
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 156
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS 156
Physical activity in liver transplant recipients: a large multicenter study 155
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease 154
Baveno IV Consensus Statements: Predictive Models in Portal Hypertension 153
Meta-analysis of Transarterial Embolization in Patients with Unresectable Hepatocellular Carcinoma: Dr Camma and colleagues respond 152
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome 151
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 151
Monitoring Treatment of Cirrhosis and Portal Hypertension 150
Reply to: “It takes two “eyes” to see in depth” 148
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment 146
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 145
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974, (S0168827821022996), (10.1016/j.jhep.2021.12.022)] 142
The OMICs window into nonalcoholic fatty liver disease (NAFLD) 142
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation 142
Totale 24.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021612 0 0 0 0 0 0 0 0 0 325 183 104
2021/20221.883 132 156 157 66 76 111 132 158 213 148 321 213
2022/20231.751 216 209 140 164 156 261 21 179 183 29 129 64
2023/20241.173 51 63 79 120 185 91 154 114 66 21 91 138
2024/20255.343 139 66 67 343 1.000 755 347 393 774 310 548 601
2025/20269.840 777 581 1.087 1.219 1.273 926 1.241 584 1.059 1.093 0 0
Totale 26.910